Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syrup Prospan vs NAC in COPD (SyProNAC)
NCT06377410Recruiting
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- May 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prospan in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoint: Cough and Sputum Assessment Questionnaire Score at 30 days. Started May 2024; status: recruiting.
02
Drugs
prospan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06377410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06377410.